TAT.ARC protein administration in the contralateral ventricle decreased lesion volume in subregions of the ischemic territory after 24 h and 72 h after 60 min middle cerebral artery occlusion
Stefan Donath(Max Delbrück Center), Christoph Harms(Charité - Universitätsmedizin Berlin), Janet Lips(Charité - Universitätsmedizin Berlin), Ulrich Dirnagl(German Center for Neurodegenerative Diseases), Gisela Lättig-Tünnemann(Stroke Association), Susanne Mueller(Charité - Universitätsmedizin Berlin), Anna Lena Dätwyler(Stroke Association), Marco Foddis(Charité - Universitätsmedizin Berlin), Golo Kronenberg(University of Zurich), Tracy D. Farr(University of Nottingham), Larissa Mosch(Stroke Association), Karen Gertz(Humboldt-Universität zu Berlin), Ulrike Grittner(Charité - Universitätsmedizin Berlin), Ulrike Harms(Stroke Association), Mustafa Balkaya(Institute of Experimental Endocrinology of the Slovak Academy of Sciences), Junfeng An, René Bernard(Charité - Universitätsmedizin Berlin), Matthias Endres(German Center for Neurodegenerative Diseases)
Cited by 1
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948